National trends in maternal use of opioid drugs among pregnancy-related hospitalizations in the United States, 1998 to 2009

American Journal of Perinatology

Volumn 32, Issue 3, 2015, Pages 289-297

  Salihu, Hamisu M ^a,b   Mogos, Mulubrhan F ^a   Salinas Miranda, Abraham A ^a   Salemi, Jason L ^a   Whiteman, Valerie E ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

opioids; pregnancy; trends; United States

Indexed keywords

NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ADULT; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; PHYSIOLOGIC MONITORING; PREGNANCY; PREGNANT WOMAN; REGRESSION ANALYSIS; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MONITORING, PHYSIOLOGIC; PATIENT DISCHARGE; PREGNANCY; PREGNANT WOMEN; PRESCRIPTION DRUGS; REGRESSION ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84929868907     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0034-1384642     Document Type: Article

References (39)

1. Substance Abuse and Maternal Health Services Adminstartion Results from the 2011 national survery on drug use and health: summary of national findings. NSDUH Series H-44. Rockville, MD SAHMSA: 2012
2. Cicero T. J., Inciardi J. A., Muñoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain: 2005; 6 10 662 672
3. Vallerand A. H. The use of long-acting opioids in chronic pain management. Nurs Clin North Am: 2003; 38 3 435 445
4. Manchikanti L., Abdi S., Atluri S., et al. American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2-guidance. Pain Physician: 2012; 15 (3, Suppl): S67 S116
5. Manchikanti L., Abdi S., Atluri S., et al. American Society of Interventional Pain Physicians. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I-evidence assessment. Pain Physician: 2012; 15 (3, Suppl): S1 S65
6. Inturrisi C. E. Clinical pharmacology of opioids for pain. Clin J Pain: 2002; 18 (4, Suppl): S3 S13
7. Trescot A. M., Datta S., Lee M., Hansen H. Opioid pharmacology. Pain Physician: 2008; 11 (2, Suppl): S133 S153
8. Kenan K., Mack K., Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000-2010. Open Med: 2012; 6 2 e41 e47
9. Paulozzi L. J., Budnitz D. S., Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf: 2006; 15 9 618 627
10. Manchikanti L., Helm S. II, Fellows B., et al. Opioid epidemic in the United States. Pain Physician: 2012; 15 (3, Suppl): ES9 ES38
11. Compton W. M., Volkow N. D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend: 2006; 81 2 103 107
12. Back S. E., Payne R. L., Simpson A. N., Brady K. T. Gender and prescription opioids: findings from the National Survey on Drug Use and Health. Addict Behav: 2010; 35 11 1001 1007
13. Bandstra E. S., Morrow C. E., Mansoor E., Accornero V. H. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis: 2010; 29 2 245 258
14. Walhovd K. B., Moe V., Slinning K., et al. Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage: 2007; 36 4 1331 1344
15. Fischer G. Treatment of opioid dependence in pregnant women. Addiction: 2000; 95 8 1141 1144
16. Patrick S. W., Schumacher R. E., Benneyworth B. D., Krans E. E., McAllister J. M., Davis M. M. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA: 2012; 307 18 1934 1940
17. Pan I. J., Yi H. Y. Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999-2008. Matern Child Health J: 2013; 17 4 667 676
18. Agency for Healthcare Research and Quality Health care Cost and Utilization Project (HCUP). Introduction to the NIS:2009, HCUP NIS related reports. Rockville, MD Agency for Healthcare Research and Quality: 2011
19. Merrill C. TTH, Owens P. LA. Reasons for being admitted to the hospital through the emergency department for children and adolescents, 2004. HCUP Statistical Brief #33. Rockville, MD Agency for Healthcare Research and Quality: 2007
20. Healthcare Cost and Utilization Project (HCUP) Agency for Healthcare Research and Quality. HCUP Quality Control Procedures. Rockville, MD; 2008
21. Kassed C. A., Levit K. R., Hambrick M. M. Hospitalizations related to drug abuse, 2005. Statistical Brief #39 Rockville, MD Healthcare Cost and Utilization Project (HCUP). Agency for Healthcare Research and Quality; 2008
22. Kim H-J, Fay M. P., Feuer E. J., Midthune D. N. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med: 2000; 19 3 335 351
23. Houchens R., Elixhauser A. Using the HCUP Nationwide Inpatient Sample to Estimate Trends. (Updated for 1988-2004). HCUP Methods Series Report #2006-05 Online U.S. Agency for Healthcare Research and Quality: 2006
24. SAS Institute Inc SAS/STAT® 9.3 User's Guide. Cary, NC SAS Institute Inc.: 2011
25. Methodology S., Branch A. Joinpoint Regression Program, Version 4.0.1-January 9, 2013. Surveillance Research Program, National Cancer Institute; 2013
26. Epstein R. A., Bobo W. V., Martin P. R., et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol: 2013; 23 8 498 503
27. Chen I., Kurz J., Pasanen M., et al. Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med: 2005; 20 7 593 598
28. Becker W. C., Starrels J. L., Heo M., Li X., Weiner M. G., Turner B. J. Racial differences in primary care opioid risk reduction strategies. Ann Fam Med: 2011; 9 3 219 225
29. Younger J. W., Chu L. F., D'Arcy N. T., Trott K. E., Jastrzab L. E., Mackey S. C. Prescription opioid analgesics rapidly change the human brain. Pain: 2011; 152 8 1803 1810
30. Birnbaum H. G., White A. G., Schiller M., Waldman T., Cleveland J. M., Roland C. L. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med: 2011; 12 4 657 667
31. Broussard C. S., Rasmussen S. A., Reefhuis J., et al. National Birth Defects Prevention Study. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol: 2011; 204 4 e1 e11
32. Joranson D. E. Federal and state regulation of opioids. J Pain Symptom Manage: 1990; 5 (1, Suppl): S12 S23
33. Joranson D. E., Gilson A. M., Dahl J. L., Haddox J. D. Pain management, controlled substances, and state medical board policy: a decade of change. J Pain Symptom Manage: 2002; 23 2 138 147
34. Federation of State Medical Boards of the United States Model guidelines for the use of controlled substances for the treatment of pain. S D J Med: 1999; 52 1 25 27
35. Center For Substance Abuse Work Group; Federation of State Medical Boards Model policy guidelines for opioid addiction treatment in the medical office. Pain Physician: 2003; 6 2 217 221
36. Federation of State Medical Boards of the United States, Inc Model policy for the use of controlled substances for the treatment of pain. J Pain Palliat Care Pharmacother: 2005; 19 2 73 78
37. Sandlin D. The new Joint Commission Accreditation of Healthcare Organizations' requirements for pain assessment and treatment: a pain in the assessment? J Perianesth Nurs: 2000; 15 3 182 184
38. Manchikanti L., Fellows B., Ailinani H., Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician: 2010; 13 5 401 435
39. Zhao J., Stockwell T., Macdonald S. Non-response bias in alcohol and drug population surveys. Drug Alcohol Rev: 2009; 28 6 648 657